Vimarsana
Biggest News Aggregation in the World

Page 8 - Van Rompay News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Van Rompay. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Van Rompay Today - Breaking & Trending Today

Mithra and Searchlight Pharma Announce Nextstellis® Approval in Canada - Vimarsana News

Mithra and Searchlight Pharma Announce Nextstellis® Approval in Canada

Mithra Logo (CNW Group/Searchlight Pharma Inc.) First E4-based product approved internationally Canadian regulatory approval is the first in the world for the novel combined oral contraceptive Nextstellis ® Approval supported by two large multinational Phase 3 studies conducted in 3,725 women Commercial launch in Canada anticipated mid-summer 2021 LIEGE, Belgium and MONTREAL, March 8, 2021 /CNW/ - Mithra and Searchlight Pharma announced today that Health Canada has approved Nextstellis ®, the first and only combined oral contraceptive (COC) product based on the unique native estrogen est...

Hyloris' Partner AFT Pharmaceuticals Signs Licensing Agreement with Aguettant for Maxigesic® IV ... - Vimarsana News

Hyloris' Partner AFT Pharmaceuticals Signs Licensing Agreement with Aguettant for Maxigesic® IV ...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Hyloris’ Partner AFT Pharmaceuticals Signs Licensing Agreement with Aguettant for Maxigesic® IV ... Hyloris PharmaceuticalsMarch 5, 2021 GMT Hyloris’ Partner AFT Pharmaceuticals Signs Licensing Agreement with Aguettant for Maxigesic® IV in Eight European Markets Footprint across Europe now extended to a total of 20 EU member states Maxigesic® IV offers a non-opioid alternative in post-operative pain management Liège, Belgium – 5 March 2021 – Hyloris Pharmaceuticals SA (Euronext Brussels:...

Source: apnews.com
Future Vaccines Depend on Test Subjects in Short Supply: Monkeys - Vimarsana News

Future Vaccines Depend on Test Subjects in Short Supply: Monkeys

Future Vaccines Depend on Test Subjects in Short Supply: Monkeys Veterinary techs distribute food every morning to more than 5,000 monkeys at the Tulane University National Primate Research Center outside New Orleans.Credit... Feb. 23, 2021 Mark Lewis was desperate to find monkeys. Millions of human lives, all over the world, were at stake. Mr. Lewis, the chief executive of Bioqual, was responsible for providing lab monkeys to pharmaceutical companies like Moderna and Johnson & Johnson, which needed the animals to develop their Covid-19 vaccines. But as the coronavirus swept across the United...

The world needs monkeys. Future vaccines depend on primate test subjects in short supply. - Vimarsana News

The world needs monkeys. Future vaccines depend on primate test subjects in short supply.

A global monkey shortage, resulting from the unexpected demand caused by the pandemic, has been exacerbated by a recent ban on the sale of wildlife from China.

Future vaccines depend on primate test subjects in short supply - Vimarsana News

Future vaccines depend on primate test subjects in short supply

A global monkey shortage, resulting from the unexpected demand caused by the pandemic, has been exacerbated by a recent ban on the sale of wildlife from China.